When does T-cell lymphoma need radiotherapy? Purpose, treatment area and planning

A radiotherapy recommendation does not automatically mean chemotherapy has failed. Its absence does not mean a necessary step has been omitted. T-cell lymphoma includes diseases in which radiation has very different roles: part of initial treatment for selected localised disease, control of a troublesome site, or treatment directed at the skin. The full entity, distribution and intended purpose come before decisions about the radiation technique.

Key takeaways

These excerpts come from the original article. Read the full sections below for context.

Selected localised PTCL or systemic ALCL cases may prompt discussion of involved-site radiation in the setting of systemic treatment. When disease involves multiple regions, treating one area cannot by itself replace a systemic strategy. The 2025 ESMO–EHA guideline relates recommendations to entity, extent and clinical circumstances rather than applying one radiation rule to the entire category. d’Amore et al.: ESMO–EHA guideline for peripheral T- and NK-cell lymphomas, 2025
Before treatment, simulation and planning use imaging to define the target and nearby structures, calculate dose and review the plan. Planning images serve a different purpose from a diagnostic scan. Even with recent imaging, the team may need data obtained in the treatment position. This is not automatically an unnecessary repetition. NCI: External Beam Radiation Therapy for Cancer
During external-beam treatment, staff monitor the patient from a control area and can communicate. Signal if pain, anxiety or another problem affects the position. Ordinary external-beam radiotherapy does not make the patient radioactive, so it does not itself require isolation from family. Separate infection or immunosuppression advice may still apply. NCI: External Beam Radiation Therapy for Cancer

Quick answer

Full guide

Bring a specific question to the consultation: which lesion, symptom or risk is this course meant to change? The answer helps explain the field, schedule and relationship to systemic treatment. It also makes it possible to determine whether two centres are proposing genuinely different strategies or simply describing different parts of one plan.

Nodal mature T-cell lymphoma needs an integrated approach

Selected localised PTCL or systemic ALCL cases may prompt discussion of involved-site radiation in the setting of systemic treatment. When disease involves multiple regions, treating one area cannot by itself replace a systemic strategy. The 2025 ESMO–EHA guideline relates recommendations to entity, extent and clinical circumstances rather than applying one radiation rule to the entire category. d’Amore et al.: ESMO–EHA guideline for peripheral T- and NK-cell lymphomas, 2025

If one abnormal focus remains after chemotherapy, the team must assess whether it represents active lymphoma, whether further evidence is needed and what local treatment could achieve. Referral to radiation oncology is not itself a diagnosis of refractory disease. Ask for the imaging basis and alternative interpretations before concluding that all previous treatment was ineffective.

NK/T-cell lymphoma can give radiotherapy a different role

Extranodal NK/T-cell lymphoma, including some localised presentations, requires a dedicated discussion of radiation integrated with systemic treatment. NCI describes a pathway that differs from conventional anthracycline-based approaches for common nodal PTCL. Planning considers the involved nasal or other structures and adjacent anatomy rather than drawing a small field around the visible surface of a mass. NCI PDQ: Peripheral T-Cell Non-Hodgkin Lymphoma Treatment

Keep pretreatment imaging, relevant local examinations and systemic staging. Initial disease extent may remain important after a mass shrinks. Sending only the most recent reassuring scan can remove information needed for planning. If nasal symptoms, pain or discharge change, the team may need to consider disease, infection and mucosal effects together.

Rapidly worsening bleeding, breathing or swallowing difficulty needs prompt clinical attention rather than waiting for a scheduled simulation appointment. Planning a radiation course takes preparation, while an immediate complication may require a separate urgent intervention. Patients should tell both the treating service and urgent-care team about the current lymphoma plan.

Skin-directed radiation does not mean equal irradiation of all internal organs

Mycosis fungoides and other selected cutaneous entities may involve local electron treatment or a broader skin-directed approach. Total skin electron beam therapy targets the skin and requires specialised equipment, physics support and expertise. NCI's professional summary also describes availability and cutaneous-toxicity limitations. Its comprehensive-sounding name does not establish that it is appropriate for every cutaneous or systemic T-cell disease. NCI PDQ: Mycosis Fungoides and Other Cutaneous T-Cell Lymphomas, professional version

The decision between treating a few lesions and addressing more extensive skin involvement depends on stage, burden, previous therapy and goals. NCI's patient summary distinguishes radiation from phototherapy and extracorporeal photopheresis. These use different processes and should not all be recorded simply as light treatment. NCI PDQ: Mycosis Fungoides and Sézary Syndrome Treatment

Relieving itch, pain or ulceration can be a meaningful objective. Improvement in skin symptoms does not establish control in blood, nodes or internal organs. The skin and haematology teams should specify their respective assessments so that a good local result does not lead to omission of systemic follow-up.

Symptom-directed treatment needs a measurable aim

Local radiation can address a painful or compressive site. Ask what change is expected, when benefit will be assessed and what happens if symptoms persist. Palliative radiation is active treatment of a particular burden, not a statement that all other care has ended. Its overlap with medicines needs coordination between the responsible clinicians. NCI: External Beam Radiation Therapy for Cancer

Suspected spinal cord compression, rapidly changing neurological function or substantial bleeding requires appropriate urgent assessment. An online description cannot establish whether waiting is safe. The cause of a local symptom must be identified, and management may involve medicines, surgery or another intervention as well as, or instead of, radiation.

Simulation designs treatment rather than delivering the course

Before treatment, simulation and planning use imaging to define the target and nearby structures, calculate dose and review the plan. Planning images serve a different purpose from a diagnostic scan. Even with recent imaging, the team may need data obtained in the treatment position. This is not automatically an unnecessary repetition. NCI: External Beam Radiation Therapy for Cancer

Head and neck treatment may use a fitted mask to help reproduce positioning. MSK's patient guide explains the mask and simulation process. Mention claustrophobia, pain, difficulty lying flat or restricted movement before the mask is made. The team can discuss support. Hiding an inability to maintain position makes consistent delivery harder rather than demonstrating cooperation. Memorial Sloan Kettering: Radiation Therapy to Your Head and Neck, 2026

Report contrast allergy, implanted devices, possible pregnancy and substantial recent weight changes. Preparation depends on the local procedure, so instructions from another hospital should not be copied without checking. Preserve markings and positioning equipment as directed and ask before changing them.

Read dose and fractions together

Total dose, dose per fraction and number of fractions belong to one plan, alongside volume, sensitive structures and previous exposure. Fewer visits do not necessarily mean weaker treatment, and a higher total dose is not automatically better for the individual. Before comparing recommendations, establish that they concern the same disease, objective, field and prior treatment history. d’Amore et al.: ESMO–EHA guideline for peripheral T- and NK-cell lymphomas, 2025

Useful questions concern the covered area, the organs that need protection, expected early and late effects and the response to an interruption. Photons, electrons and protons have different physical properties, but a machine's name cannot prove superior lymphoma outcomes. The clinician should explain the actual target-coverage or normal-tissue benefit expected in this person's plan. NCI: External Beam Radiation Therapy for Cancer

Previous radiation records matter for another course

Provide the location, dates, delivered dose and fractions of earlier treatment, together with the original plan where possible. “Radiation to the chest” or “ten sessions” is insufficient for assessing overlap. Radiation oncologists need to consider cumulative exposure, elapsed time and the condition of normal tissues, and may request electronic planning data directly from the original institution.

For continuation or re-treatment in China, confirm the receiving team's data requirements and whether new simulation is necessary. An interrupted course cannot be transferred simply by subtracting completed appointments from a new centre's schedule. Complete the clinical and planning review before relying on a generic course length to purchase inflexible return travel.

Side effects depend on the area and accompanying treatment

Head and neck fields can affect the mouth, taste, swallowing and salivary function. Chest treatment can produce swallowing or respiratory symptoms, while abdominal or pelvic fields can affect gastrointestinal or urinary function. NCI groups radiation effects by the treated area and notes that some later effects arise after treatment. Ask about the relevant field rather than assuming every listed complication is expected. NCI: Radiation Therapy Side Effects

If the mouth or throat lies within the field, dental assessment, oral care and symptom monitoring may be part of preparation. NCI's oral-complication information supports coordination with the treatment team. Difficulty drinking, substantial ulceration or continuing weight loss deserves early reporting so supportive care can be adjusted. Silence does not make a course easier to complete. NCI PDQ: Oral Complications of Cancer Therapies

Nutrition specialists can tailor support to swallowing, gastrointestinal symptoms and usual food preferences. NCI's nutrition guidance treats reduced intake as a problem needing a specific assessment; an expensive supplement cannot guarantee prevention of radiation effects. Actual intake, weight trend and the timing of symptoms are more informative than a general statement of poor appetite. NCI PDQ: Nutrition in Cancer Care

Understand safety during and after the course

During external-beam treatment, staff monitor the patient from a control area and can communicate. Signal if pain, anxiety or another problem affects the position. Ordinary external-beam radiotherapy does not make the patient radioactive, so it does not itself require isolation from family. Separate infection or immunosuppression advice may still apply. NCI: External Beam Radiation Therapy for Cancer

Fever, wounds or unusual skin changes should not automatically be attributed to radiation. NCI explains that infection during cancer treatment may need urgent assessment. If a session is missed, contact the centre; patients cannot compensate by doubling a later dose or arranging an uncoordinated session on another machine. NCI: Infection and Neutropenia during Cancer Treatment

At completion, obtain a treatment summary with the site, dates, actual dose and fractions, significant reactions and follow-up arrangements. A receiving clinician in the home country needs to know what to monitor and who will interpret the first follow-up scan. Some reactions can persist after the last session, so completing the course is not proof that the body has fully recovered that day.

The consultation should leave the patient able to explain why radiation was chosen, what part of the disease it addresses and how it fits with the rest of care. That understanding is more durable than memorising a device name or a fraction count, and it makes later changes easier to discuss with any team involved.